Colorcon and TruTag Technologies Enter into Development Agreement Targeting Authentication of Medicines
Colorcon and TruTag Technologies, Inc. today announced execution of a development agreement to enable on-dose verification technology for tablets by combining TruTag’s silica-based microtag authentication technology with Colorcon’s industry-leading expertise in film coating systems, modified release technologies and specialty excipients.
The collaboration will see TruTag’s edible “optical barcodes” incorporated into existing Colorcon coatings, with the microtags verified by either a smart phone application or a proprietary reader. Each SiO2 particle is encoded with an optical signature that is manufactured into the microtags without the use of additional additives or markers.
The benefits of this innovation include the ability to
instantly and unequivocally authenticate products when suspect events occur and specifically
addresses the problems of counterfeiting, product diversion, returns monitoring, quality control and
product recalls in pharmaceuticals and nutraceuticals.
“On-dose authentication technology represents the next
generation in pharmaceutical supplychain security by providing a powerful tool for tracking product
from plant to patient,” said Kelly Boyer, General Manager, Film Coatings of Colorcon. “By
seamlessly enabling authentication, these digitized coatings confirm the quality
and origin of medicines thereby safeguarding both patients and brands. Colorcon continues to
advance technologies and services to meet industry challenges with innovative solutions.”
“Colorcon brings a shared vision for bringing innovation to
the pharmaceutical industry, said Michael Bartholomeusz, CEO of TruTag Technologies. “They are
market leaders in the filmcoating space, and they have the caliber and reach to make intelligent
coatings a new industry standard. We are thrilled to be working with them.”
